Novo Nordisk Still Sees Potential for GLP-1 Drugs in Alzheimers...

een koppeling hebt gedeeld

2025-12-04 10:00:02

Novo Nordisk Still Sees Potential for GLP-1 Drugs in Alzheimers Despite Major Trial Setbacks

By Blessing NwekeNovo Nordisk says it remains optimistic that GLP-1 drugs could play a role in treating Alzheimers disease, even after two highly anticipated trials found no evidence that an older

0 Reacties 0 aandelen 18 Views